Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr;58(4):344-50.
doi: 10.4097/kjae.2010.58.4.344. Epub 2010 Apr 28.

Comparison of coagulation factors and blood loss between O and non-O blood types following hydroxyethyl starch infusion

Affiliations

Comparison of coagulation factors and blood loss between O and non-O blood types following hydroxyethyl starch infusion

Soo Joo Choi et al. Korean J Anesthesiol. 2010 Apr.

Abstract

Background: Individuals with type O blood are more likely to have reduced factor VIII and von Willebrand factor levels compared to their non-O counterparts. Hydroxyethyl starch (HES), which is widely used for blood volume replacement, can induce coagulopathy. Therefore, we tested whether blood type O patients show more coagulopathy and blood loss than non-O patients after infusion of 6% HES.

Methods: Thirty-four non-O and 20 type O patients scheduled for posterior lumbar interbody fusion (PLIF) involving 3 vertebrae or less from June 2007 to August 2008 were enrolled. Fifteen ml/kg of 6% HES was administered during the operation. Coagulation profiles was checked at pre-infusion (T0), 5 min after the end of infusion (T1), 3 hr after the end of infusion (T2), and 24 hr after the end of infusion (T3). Bleeding was measured during and after surgery for 24 hours.

Results: Baseline factor VIII concentration was lower and aPTT was longer in type O patients compared to those of non-O patients. 6% HES infusion decreased most of the coagulation factors at T1 in both groups, which were recovered in a time dependent manner. Factor VIII and aPTT of blood type O patients fell off the normal range at T1. However, other coagulation factors, thromboelastography variables, and blood loss were not different between the groups.

Conclusions: Despite inborn low factor VIII which further decreased shortly after HES infusion, blood type O patients did not show more blood loss than non-O blood type after 15 ml/kg of HES infusion in PLIF surgery.

Keywords: Blood loss; Blood type; Coagulation; Factor VIII; Hydroxyethyl starch; Thromboelastography.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Factor VIII was lower in the O group compared to the non-O group before HES infusion and throughout the study period. T0: preinfusion, T1: 5 min after infusion, T2: 3 hr after infusion, T3: 24 hr after the end of infusion. *P < 0.05 between Non-O and O groups. Error bars are SD.
Fig. 2
Fig. 2
Comparison of proportional changes of hematocrit and Factor VIII after HES infusion at T1. There were no differences between hematocrit and Factor VIII in both groups. Error bars are SD.
Fig. 3
Fig. 3
aPTT was prolonged in the O group compared to the non-O group before HES infusion and throughout the study period. T0: preinfusion, T1: 5 min after infusion, T2: 3 hr after infusion, T3: 24 hr after the end of infusion. *P < 0.05 between non-O and O groups. Error bars are SD.

Similar articles

Cited by

References

    1. Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med. 1999;25:258–268. - PubMed
    1. Collis RE, Collins PW, Gutteridge CN, Kaul A, Newland AC, Williams DM, et al. The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study. Intensive Care Med. 1994;20:37–41. - PubMed
    1. Treib J, Haass A, Pindur G. Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost. 1997;78:974–983. - PubMed
    1. Boldt J, Knothe C, Zickmann B, Andres P, Dapper F, Hempelmann G. Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass. Anesth Analg. 1993;76:1185–1190. - PubMed
    1. Innerhofer P, Fries D, Margreiter J, Klingler A, Kuhbacher G, Wachter B, et al. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg. 2002;95:858–865. - PubMed

LinkOut - more resources